Fibroblast growth factors 19 and 21 in acute liver damage

Currently there are very few pharmacological options available to treat acute liver injury. Because its natural exposure to noxious stimuli the liver has developed a strong endogenous hepatoprotective capacity. Indeed, experimental evidence exposed a variety of endogenous hepatic and systemic respon...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Transl Med
Autors principals: Shan, Zhao, Alvarez-Sola, Gloria, Uriarte, Iker, Arechederra, María, Fernández-Barrena, Maite G., Berasain, Carmen, Ju, Cynthia, Avila, Matías A.
Format: Artigo
Idioma:Inglês
Publicat: AME Publishing Company 2018
Matèries:
Review Article on Molecular Hepatology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6046301/
https://ncbi.nlm.nih.gov/pubmed/30069459
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2018.05.26
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars